Well Done LLC’s Gilead Sciences GILD Stock Holding History

Well Done LLC’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-512	Closed	-$32K	–	343
2018 Q4	$32K	Buy	+512	New	+$35.8K	0.01%	300
2018 Q2	–	Sell	-830	Closed	-$63K	–	276
2018 Q1	$63K	Buy	+830	New	+$66K	0.02%	212

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Well Done LLC's GILD Position: Q1 2019 in Review

Well Done LLC sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 512 shares — an estimated $32K sold.

Well Done LLC first reported a position in GILD in Q1 2018 and held it in 2 quarters. The position peaked at $63K in Q1 2018. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

Well Done LLC reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
Well Done LLC sold 512 Gilead Sciences shares in Q1 2019, an estimated $32K.
Well Done LLC first reported a position in Gilead Sciences in Q1 2018 and held it in 2 quarters.
Well Done LLC's Gilead Sciences position peaked at $63K in Q1 2018.
1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Well Done LLC's 13F filing for Q1 2019, filed 9 May 2019.